Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: john.d who wrote (6515)	1/19/2001 10:35:26 PM
From: Montana Wildhack	Respond to of 14101

John, Good post. Those are the points. She just moved everything out of her way, has big plans, and wants to get busy. We're still getting cash on top of this from revenue, UK, and Europe. Europe deal I guess at 2 months away and absolutely no less than $15 million Canadian. It'll be interesting to see what the markets do on Monday. If experience continues it won't do anything. Joe's already pointed out it didn't hurt Hemosol. Wolf

To: john.d who wrote (6515)	1/19/2001 10:38:52 PM
From: Mark Bartlett	Read Replies (1) \| Respond to of 14101

John, I share your feelings and think your analysis was excellent. While one can certainly read some potential negatives into the deal, I like the flexibility very much and overall it is a very good deal. Well done, Rebecca. MB

To: john.d who wrote (6515)	1/19/2001 11:52:04 PM
From: Mike Jubian	Respond to of 14101

John, FWIW 1)& 2) agree 3) true, but Wolf has a good point about HC 4) & 5) too many options here, I do see OXO/DIME relationship healthy 6) true, however IMHO a price over $25 increases risk in a volatile sector under these terms. 7) we know what Rebecca can accomplish with $10 million, with $50 million that's POWER 8) the terms for UK deal are not known, up front payment might not necessarily be up front. As you said this deal is very flexible. 9) IMO we will not see a NASDAQ listing until we have solid revenues with growth, EPS on the NASDAQ is were the money is made. I also think this is positive for DMX and shareholders. MJ